| Product Code: ETC7211759 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Age-Related Macular Degeneration Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Age-Related Macular Degeneration Market Revenues & Volume, 2021 & 2031F |
3.3 France Age-Related Macular Degeneration Market - Industry Life Cycle |
3.4 France Age-Related Macular Degeneration Market - Porter's Five Forces |
3.5 France Age-Related Macular Degeneration Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 France Age-Related Macular Degeneration Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 France Age-Related Macular Degeneration Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 France Age-Related Macular Degeneration Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing aging population in France |
4.2.2 Technological advancements in diagnosis and treatment of age-related macular degeneration |
4.2.3 Growing awareness about eye health and early detection of age-related macular degeneration |
4.3 Market Restraints |
4.3.1 High cost of treatment and medications |
4.3.2 Limited access to specialized healthcare services in certain regions of France |
4.3.3 Regulatory hurdles and approval processes for new treatments |
5 France Age-Related Macular Degeneration Market Trends |
6 France Age-Related Macular Degeneration Market, By Types |
6.1 France Age-Related Macular Degeneration Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 France Age-Related Macular Degeneration Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 France Age-Related Macular Degeneration Market Revenues & Volume, By Eylea, 2021- 2031F |
6.1.4 France Age-Related Macular Degeneration Market Revenues & Volume, By Lucentis, 2021- 2031F |
6.1.5 France Age-Related Macular Degeneration Market Revenues & Volume, By Beovu, 2021- 2031F |
6.1.6 France Age-Related Macular Degeneration Market Revenues & Volume, By Others, 2021- 2031F |
6.2 France Age-Related Macular Degeneration Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 France Age-Related Macular Degeneration Market Revenues & Volume, By Dry AMD, 2021- 2031F |
6.2.3 France Age-Related Macular Degeneration Market Revenues & Volume, By Wet AMD, 2021- 2031F |
6.3 France Age-Related Macular Degeneration Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 France Age-Related Macular Degeneration Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 France Age-Related Macular Degeneration Market Revenues & Volume, By Specialty Pharmacy, 2021- 2031F |
6.3.4 France Age-Related Macular Degeneration Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 France Age-Related Macular Degeneration Market Import-Export Trade Statistics |
7.1 France Age-Related Macular Degeneration Market Export to Major Countries |
7.2 France Age-Related Macular Degeneration Market Imports from Major Countries |
8 France Age-Related Macular Degeneration Market Key Performance Indicators |
8.1 Number of patients diagnosed with age-related macular degeneration annually |
8.2 Adoption rate of new diagnostic technologies in detecting age-related macular degeneration |
8.3 Percentage of healthcare professionals trained in managing age-related macular degeneration |
8.4 Research and development investment in new treatments for age-related macular degeneration |
8.5 Patient satisfaction scores with available treatment options |
9 France Age-Related Macular Degeneration Market - Opportunity Assessment |
9.1 France Age-Related Macular Degeneration Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 France Age-Related Macular Degeneration Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 France Age-Related Macular Degeneration Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 France Age-Related Macular Degeneration Market - Competitive Landscape |
10.1 France Age-Related Macular Degeneration Market Revenue Share, By Companies, 2024 |
10.2 France Age-Related Macular Degeneration Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here